Insurance Coverage

One of the biggest barriers to accessing GLP-1 weight loss medications is cost. Understanding how insurance coverage works can help you advocate for reimbursement.

Private Insurance Plans

Coverage varies significantly between insurance providers and specific plans.

• Obesity vs. Diabetes: Many plans cover Ozempic and Mounjaro readily for Type 2 Diabetes. However, coverage for Wegovy or Zepbound (specifically for weight loss) is more restrictive.
• Employer Opt-Ins: Even if a major carrier offers coverage, your specific employer may have opted out of covering weight loss drugs.
• Prior Authorization (PA): Most insurers require a PA. Your doctor must submit documentation proving medical necessity (e.g., BMI records, history of failed diet attempts).

Government Healthcare Programs

Coverage rules for government-funded programs are strict but evolving.

• Medicare: Historically, Medicare has been prohibited by law from covering weight loss medications. However, new guidance allows coverage for Wegovy if prescribed to reduce the risk of heart attacks and strokes in people with cardiovascular disease (who also have obesity/overweight).
• Medicaid: Coverage varies by state. Some states cover anti-obesity medications, while others do not.

Savings Cards & Programs

If your insurance denies coverage, manufacturers often offer savings programs:

• Commercial Insurance Card: Reduces copay if your insurance covers the drug.
• Cash Pay Programs: Some manufacturers offer a discount (e.g., ~$500 off per month) for patients whose insurance denies coverage, though the out-of-pocket cost remains high (often $500–$1000/month).